Howard Benjamin is VP at REPLIGEN CORP (RGEN). They have made 7 open-market trades across 1 company since 2014, most recently 2017-12-14.
CIK 0001393547
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RGEN | 33,908 | $6.0M |
Shares reported on the most recent Form 4, priced at the 2017-12-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGEN | SELL | 2017-12-14 | 2017-12-18 | $35.34 | $900K | -0.1% | -2.8% | -1.5% |
| RGEN | SELL | 2017-03-20 | 2017-03-22 | $34.62 | $846K | -0.5% | +3.1% | +15.1% |
| RGEN | SELL | 2016-05-11 | 2016-05-13 | $26.72 | $154K | -5.3% | -13.5% | +17.8% |
| RGEN | SELL | 2015-06-08 | 2015-06-10 | $38.14 | $1.3M | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2015-03-18 | 2015-03-19 | $32.63 | $515K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2014-11-11 | 2014-11-12 | $23.56 | $707K | -17.5% | +0.7% | +0.7% |
| RGEN | SELL | 2014-08-13 | 2014-08-14 | $20.34 | $814K | -17.5% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.